The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.
1 min read
Summary
Reaction to plans announced by the US Food and Drug Administration to limit access to covid vaccines to primarily vulnerable groups, with others needing to wait, has been fearful and angry in some quarters.
However, the author argues that, while the decision has been controversial, it should not be a surprise given a similar approach has been taken in the UK for some time.
Covid vaccines have been a remarkable success and have both saved lives and ended lockdowns, but questions have been asked about the need for annual booster shots.
The author welcomes the decision to require evidence of a drug’s benefits before widening access, but concerns remain, including whether healthy individuals should be able to choose to get one.
The decision means that and who will be able to access covid vaccinations under the new plans remains unclear.